Financing channel feed – Endpoints News

Financing channel feed

A look at biotech's year of the megaround

4 months ago

Sofinnova outlines $550M fund after IPOs and M&A deals

4 months ago

Exclusive: Florida cancer biotech raises $100M Series A

4 months ago

2025 could bring some sunshine for health tech startups

4 months ago

Exclusive: Color Health alums raise $10M for new startup, using AI for regulatory work

4 months ago

David Epstein gets $140M for Ottimo's bifunctional take on hot PD-1xVEGF field

4 months ago

SiteOne Therapeutics, a pain biotech that's partnered with Vertex, nabs $100M

4 months ago

Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic

5 months ago

Exclusive: Bain-backed musculoskeletal biotech raises $120M for trio of clinical-stage biologics

5 months ago

Exclusive: Negev Labs unveils with $30M in assets, striving to build a network of psychedelic biotechs

5 months ago

Exclusive: Two Vida Ventures co-founders exit the VC firm

5 months ago

New oncology biotech launches with $52M in its pocket

5 months ago

Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning

5 months ago

Dutch biotech nabs €85M to position inflammatory antibody for a pharma buyer

5 months ago

Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune field

5 months ago

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

5 months ago

After deal about-face and a spinout, Maze assembles $115M Series D

5 months ago

Revolution sells $600M in shares on back of RAS inhibitor portfolio updates

5 months ago

Agenus launches biologics manufacturing business to generate cash

5 months ago

Why Morgan Health is backing an autism care company

5 months ago

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

5 months ago

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

5 months ago

Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

5 months ago

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy

5 months ago

First page Previous page 3 4 567 8 9 Next page Last page